You are here

  • Home
  • Archive
  • Volume 5, Issue Suppl 1
  • PS2:28 Autoantibody profiling in prostvac and ipilimumab treated prostate cancer patients reveals potential biomarkers of immune-related adverse events

Article metrics

Article menu

Download PDFPDF

Poster session 2: Autoantibodies, biomarkers and imaging (2), Environmental, epigenetics and genomics
PS2:28 Autoantibody profiling in prostvac and ipilimumab treated prostate cancer patients reveals potential biomarkers of immune-related adverse events
Free

 

Online download statistics by month:

Online download statistics by month: March 2018 to September 2024

AbstractFullPdf
Mar 201822010
Apr 20181000
May 20182004
Jun 20183004
Jul 20181605
Aug 20181201
Sep 20181203
Oct 20181202
Nov 2018601
Dec 20182001
Jan 20196001
Feb 2019400
Mar 2019601
Apr 2019002
May 2019300
Jul 20191301
Aug 2019801
Sep 2019200
Oct 20191000
Nov 2019402
Dec 2019402
Jan 20201200
Feb 2020400
Mar 2020301
Apr 2020600
May 20201403
Jun 2020500
Jul 20201801
Aug 20201300
Sep 20201202
Oct 20201303
Nov 2020401
Dec 2020802
Jan 2021600
Feb 2021003
Mar 2021201
Apr 2021201
May 2021402
Jun 2021004
Jul 2021003
Aug 2021001
Sep 2021004
Oct 20218016
Nov 202110013
Dec 2021601
Jan 20221406
Feb 2022300
Mar 20222202
Apr 2022603
May 2022606
Jun 20222004
Jul 20222002
Aug 20221402
Sep 2022605
Oct 2022805
Nov 20221009
Dec 2022800
Jan 20231002
Feb 2023201
Mar 2023200
Apr 2023001
Jun 2023201
Jul 2023602
Aug 2023202
Sep 2023402
Oct 20231100
Nov 2023400
Dec 20231801
Jan 2024202
Feb 20241103
Mar 202410057
Apr 2024605
May 2024806
Jun 20242004
Jul 20242207
Aug 20241002
Sep 20241003
Total7210248